AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.
Exelixis, Inc.
Click here to visit Company website
Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously.
View Online Reports:
Order Free Hardcopy
You can request a free hardcopy of this report mailed to you by clicking the button below.
No investor fact sheets added yet
No responsibility reports added yet
